Archives
-
Tropisetron Hydrochloride: Assay Workflows
2026-08-20
Build receptor and renal transporter assays around Tropisetron Hydrochloride, using its 5-HT3 activity to interrogate serotonin biology and its transporter effects to model drug–drug interaction risk. The workflow combines concentration-aware pharmacology, polarized cell transport, and practical troubleshooting for reproducible research.
-
Erastin as a Redox-Threshold Probe for Ferroptosis
2026-08-20
Erastin is a ferroptosis inducer that reveals how cystine, glutathione, iron, and lipid oxidation interact to determine cell fate. This guide connects tumor-cell assays with findings from aging lens epithelium to improve experimental interpretation and model selection.
-
MK-8745 Aurora A Inhibitor for Cell Assays
2026-08-19
A scenario-based guide to using MK-8745, Aurora A inhibitor, potent and selective (SKU A8807) in cell viability, proliferation, cell-cycle, and apoptosis workflows. It connects assay design, formulation, interpretation, and model selection to product-documented quantitative parameters and relevant Aurora A literature.
-
OCT2 and MATE1 Inhibition by Antiemetic Drugs
2026-08-19
George and colleagues evaluated how five 5-HT3 receptor antagonist drugs interfere with the renal organic cation transporters OCT2 and MATE1. Their cell-based results identify compound-specific inhibition profiles and show why transporter-mediated drug interactions should be considered when studying antiemetic pharmacology and cationic drug clearance.
-
From Pheromone Signals to Precision PCR
2026-08-18
Translational neurogenetics increasingly depends on connecting environmental cues, developmental signaling, and adult neurodegeneration to precise sequence-level evidence. This thought-leadership article examines how the C. elegans pheromone study reframes experimental priorities and why a proofreading DNA polymerase, particularly HyperFusion™ high-fidelity DNA polymerase, can strengthen validation across GC-rich, long, and inhibitor-laden templates.
-
5-hme-dCTP: A Smarter 5hmC Assay Framework
2026-08-18
5-hme-dCTP enables controlled studies of hydroxymethylated DNA and DNA polymerase behavior. This guide focuses on assay interpretation, controls, and how rice drought-response evidence should shape experimental design.
-
QNZ (EVP4593): NF-κB Pathway Research Guide
2026-08-17
QNZ, also known as EVP4593, is a quinazoline derivative used for NF-κB signaling pathway modulation. Product data report nanomolar activity in Jurkat T-cell reporter assays and research utility in inflammation and Huntington’s disease models, while emphasizing assay-specific interpretation and careful solvent handling.
-
SM-164 Workflow for Apoptosis Assays
2026-08-17
SM-164 provides a practical way to connect rapid IAP engagement with TNFα-dependent apoptosis and downstream caspase activity in tumor-cell models. This workflow combines target-degradation kinetics, orthogonal cell-death measurements, and troubleshooting guidance for reproducible cancer research assays.
-
Cy7 NHS Ester: Practical Labeling Protocol
2026-08-16
Cy7 NHS ester (SKU A8109) provides a water-soluble near-infrared dye for bioimaging of proteins and peptides through amino-group labeling. It is suited to aqueous biomolecule conjugation and imaging workflows, but reaction conditions, labeling density, live-cell compatibility, and in vivo performance should be validated for each target rather than inferred from product specifications.
-
Artemisinin, Nrf2, and Ferroptosis in Diabetic Cognition
2026-08-15
Wang et al. show that artemisinin improves learning and memory in STZ-induced T2DM mice while reducing hippocampal CA1 neuronal ferroptosis through Nrf2-associated antioxidant responses. Pharmacological blockade with ML385 and induction with erastin strengthen the study’s mechanistic conclusion and provide a useful framework for testing oxidative stress pathways in diabetic cognitive impairment.
-
Cisplatin Assay Design: From DNA Damage to Response
2026-08-14
Cisplatin and CDDP are powerful tools for linking DNA crosslink formation to apoptosis, oxidative stress, and treatment response. This guide presents an assay-design framework that connects molecular endpoints with xenograft interpretation and clinical context.
-
AZD8055: Practical mTOR Inhibition Guide
2026-08-14
AZD8055 (SKU A8214) is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolism. This dossier-based guide covers stock preparation, assay design, QC, and troubleshooting; it should not be used to infer clinical efficacy or replace optimization in aqueous protocols.
-
MDL 28170: A Selective Calpain Inhibitor Workflow
2026-08-13
MDL 28170 combines cell permeability, brain exposure, and nanomolar cysteine-protease inhibition for mechanistic neuroprotection research. This workflow connects calpain target engagement with BDNF/TrkB signaling, synaptic structure, apoptosis assays, and translational injury models.
-
Phenothiazines, ROS, and Autophagy in Macrophage Defense
2026-08-13
The 2025 Frontiers in Immunology study shows that phenothiazines can strengthen macrophage antibacterial activity by coordinating lysosomal function, autophagy, and reactive oxygen species accumulation. Pharmacological inhibition of autophagy or ROS reduced this effect, while perphenazine improved infection-associated tissue outcomes in a Salmonella Typhimurium model, supporting phenothiazines as host-directed therapy leads rather than conventional antibiotics.
-
SCH772984: Mapping ERK-Driven Tumor Resistance
2026-08-12
A translational framework for using SCH772984, a selective ERK1/2 inhibitor, to test whether MAPK signaling connects angiotensin II, HIF-1α-HILPDA biology, ferroptosis suppression, and radioresistance in nasopharyngeal carcinoma.